Dr Michal Wlodarski, MPharm (Lond), PhD (Cantab), is a Co-founder & Chief Operating Officer at Solvemed, where he leads specialised world-class teams to bring cutting-edge digital products into clinical care and neuroscience research. Trained as a scientist, with a PhD in biological sciences from the University of Cambridge, his decade-long career in healthcare and life sciences has spanned research and commercial posts at GlaxoSmithKline, National Health Service England, among others. As an Honorary Lecturer at the University College London’s Institute of Ophthalmology (Brain Sciences Faculty) and the School of Management, he trains PhD- and Masters-level students in healthcare technology innovation. More recently, he has been appointed an Adj. Professor at the IE Business School in Madrid, where he shares his experience in entrepreneurship and emerging technology to help raise the next generation of venture builders. Michal is passionate about patient-centric care and innovating clinical care and drug development, and frequently shares his perspectives as a speaker at international conferences.Demonstrated consistently the ability to initiate and develop high-performance teams and successful professional relationships, establish effective strategic partnerships with public and private organisations, generate revenue streams, manage diverse stakeholders and expert teams, and lead the delivery of complex high-stake life science innovation projects in high-pace international environments.Key areas of interest: digital/semi-digital biomarkers, software medical devices, digital-first health care, decentralised/virtual trials, predictive/preventative/personalised care, neuroTech, venture capital, entrepreneurship, business education, mentoring.Google Scholar profile: https://scholar.google.pl/citations?view_op=list_works&hl=en&hl=en&user=WtOtvmoAAAAJ